CRISPR Therapeutics AG (CRSP)
CRISPR Therapeutics Market Cap : 5.346B for April 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 110.33B |
| Novartis AG | 285.65B |
| EvoNext Holdings SA | 8.149M |
| Kuros Biosciences Ltd. | 1.089B |
| Basilea Pharmaceutica AG | 853.56M |
Market Cap Related Metrics
| PS Ratio | 1426.55 |
| PEG Ratio | -0.1729 |
| Price to Book Value | 2.782 |
| Price | 55.70 |
| Earnings Yield | -11.70% |
| PEGY Ratio | -0.1729 |